http://pastport.jp/user/canatpeptide ja-JP In 2023, the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) hit a significant milestone, approving 55 new drugs, an increase of nearly 50% from last year and second only to the all-time high of 2018 . 2024-01-19T10:30:15+0900 http://pastport.jp/user/canatpeptide/timeline/Novel%20Drug%20Approvals%20for%202023 canatpeptide http://pastport.jp/user/canatpeptide/timeline/Novel%20Drug%20Approvals%20for%202023